Filing Flows › Xencor (XNCR) › Recalls, complaints & regulation
Xencor (XNCR): clinical trials
Xencor (XNCR) beyond its filings: 8 active clinical trials.
Xencor's latest quarter
Xencor, Q3 2026: revenue $117M (+455% year over year), operating margin 19.6%, net earnings $39.4M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Xencor have?
8 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.